Free shipping on all orders over $ 500

Bozitinib (PLB-1001)

Cat. No. M10433
Bozitinib (PLB-1001) Structure
Synonym:

CBT-101; APL-101; CBI-3103

Size Price Availability Quantity
5mg USD 264  USD330 In stock
10mg USD 396  USD495 In stock
25mg USD 712  USD890 In stock
50mg USD 1160  USD1450 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
  • Current batch:
  • Purity >99%
  • COA
  • MSDS
Biological Activity

Bozitinib (PLB-1001; CBT-101) is a highly selective, blood-brain barrier permeable c-MET kinase inhibitor. Bozitinib (PLB-1001) is a ATP-competitive small-molecule inhibitor, binds to the conventional ATP-binding pocket of the tyrosine kinase superfamily.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

Chemical Information
Molecular Weight 424.38
Formula C20H15F3N8
CAS Number 1440964-89-5
Purity >99%
Solubility DMSO 50 mg/mL
Storage at -20°C
References

[1] Huimin Hu, et al. Cell. Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor

Related c-Met Products
BAY-474

BAY-474 is an inhibitor of tyrosine-protein kinase c-Met and can act as an epigenetics probe.

AMG-1

AMG-1 (c-Met/RON Dual Kinase Inhibitor, RON-IN-1) is a potent inhibitor of human c-Met and RON with IC50 of 4 nM and 9 nM, respectively.

JNJ-38877618

JNJ-38877618 (OMO-1) is a potent, highly selective, orally bioavailable MET kinase inhibitor with binding affinity (Kd) of 1.4 nM and enzyme inhibitory activity against wt and M1268T mutant MET (2 and 3 nM IC50).

SAR125844

SAR125844 is a potent intravenously active and highly selective MET kinase inhibitor, displaying nanomolar activity against the wild-type kinase (IC50 value of 4.2 nmol/L) and H1094Y, Y1235D, M1250T, L1195V, and D1228H kinase domain mutants (IC50 values of 0.22, 1.7, 6.5, 65, and 81 nmol/L, respectively).

WAY-354831

WAY-354831 is a inhibitor of c-Met kinase.

  Catalog
Abmole Inhibitor Catalog




Keywords: Bozitinib (PLB-1001), CBT-101; APL-101; CBI-3103 supplier, c-Met, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.